Open access peer-reviewed chapter

Essential Oils’ Potential in Breast Cancer Treatment: An Overview

Written By

Isadora de Fátima Braga Magalhães, Carla Junqueira Moraga Tellis, Kátia da Silva Calabrese, Ana Lucia Abreu-Silva and Fernando Almeida-Souza

Submitted: November 12th, 2019 Reviewed: February 17th, 2020 Published: May 16th, 2020

DOI: 10.5772/intechopen.91781

From the Edited Volume

Essential Oils

Edited by Mozaniel Santana de Oliveira, Wanessa Almeida da Costa and Sebastião Gomes Silva

Chapter metrics overview

1,095 Chapter Downloads

View Full Metrics


Essential oils are widely used in the pharmaceutical industry for their antimicrobial, antiviral, antifungal, antiparasitic, and insecticidal properties. Their anticancer activity has been increasingly explored as the natural constituents of essential oils play an important role in cancer prevention and treatment. The chemical composition of essential oils includes monoterpenes, sesquiterpenes, oxygenated monoterpenes, phenolic sesquiterpenes, and others. Several mechanisms of action such as antioxidant, antimutagenic, antiproliferative, enhancement of immune functions, modulation of multidrug resistance, and synergistic mechanism of volatile constituents are responsible for their chemotherapeutic properties. This review focuses on the activity of essential oils and their chemical composition in regard to breast cancer.


  • essential oils
  • antitumor activity
  • chemical composition
  • antitumor mechanism
  • breast cancer

1. Introduction

Cancer is a disease in which normal cells change into a type of cell that can continuously proliferate and, by a process named metastasis, migrate to distant parts of the body [1]. Breast cancer (BC) is the most common cancer in women in the world, presenting high morbidity and mortality [2]. It causes a major public health problem, and the incidence is increasing all over the world [3].

The treatment used for cancer causes many side effects; besides, there are a large number of cases of resistance toward anticancer drugs [4]. These are the main causes that limit the success of treatment in aggressive BC cases. Thus, the need to have novel therapeutic agents is urgent [2].

Natural products, such as plants, may hold the future of BC treatment as the source for new drugs that can interfere with certain processes and ultimately result in clinical usage as an adjuvant therapy [1].

Essential oils (EOs) act as protective mechanism for plants against bacteria, viruses, insects, and even herbivores [5]. They are widely used by the population to treat cancer and can change the metabolism of cancer cells in very low doses, besides provide energy for synthetic processes [6]. This way, EOs are being considered as a promising agent opening venues for novel anticancer therapy as a way to defeat side effects and the high cost of chemotherapy approaches in BC [7]. This review focuses on apoptosis as an action mechanism by EOs in breast cancer cells, antitumoral activity of EOs and their bioactive compounds, and optimization of EOs’ use and their potential as an alternative for side effects reduction during breast cancer treatment.


2. Induction of apoptosis in breast cancer cells by essential oils

Apoptosis is a cellular process involved in physiological and pathological conditions. The mechanism of apoptosis plays an important role in the pathogenesis of many diseases, such as cancer, in which it can be reduced by the cells as a mechanism of survival so they can continue to proliferate, leading to metastasis and resistance to drugs. Caspases can act as initiators and executers of this process and can be activated in an intrinsic or extrinsic way. The intrinsic, or mitochondrial, pathway is controlled by proteins from the Bcl-2 family, which can be proapoptotic proteins such as Bax, Bak, Bad, Bcl-Xs, Bid, Bik, Bim, and Hrk, or antiapoptotic such as Bcl-2, Bcl-XL, Bcl-W, Bfl-1, and Mcl-1 [8].

Collected from Kerman, Golestan, and East Azerbaijan provinces from Iran, EO from the seed of Foeniculum vulgar Mill, known as fennel (FN), increased the expression of a proapoptotic factor Bax and decreased antiapoptotic factor Bcl2 gene expression, which leads to cytotoxic effects on MCF7 [7]. FN also had action against MDA-MB [9]. But the FN from Tajikistan presented low cytotoxicity when compared to doxorubicin [10].

Another plant in Iran, Oliveria decumbens, is used as a vegetable and medicinal plant by the population to treat cancer-related symptoms. Its EO (OEO) inhibited viability of murine mammary carcinoma 4T1, promoting apoptosis in vitro and led to a TH1 anticancer response in 4T1 tumor-challenging mice [11]. OEO and its main component, thymol, also showed anticancer properties in MDA-MB-231 BC monolayers by activation of intrinsic and maybe extrinsic apoptosis [12]. Also, in Iran, all EOs obtained from the aerial parts of Zhumeria majdae collected from five different localities were active and did not show cytotoxicity variability for MCF7 [13].

EO of Decatropis bicolor (Zucc.) Radlk, empirically used in Mexico for BC treatment, showed a selective cytotoxic effect toward MDA-MB-231 by activation of Bax and caspases 9 and 3 through intrinsic apoptosis pathway [14]. The apoptosis of MCF7 was stimulated by Ocimum sanctum EO with the regulation of apoptotic genes p53 and Bid and elevation of Bax/Bcl-2 [15]. Similar results were found with MCF7 apoptosis induction by Tetraclinis articulata [16] and Myrtus communis L., commonly used in Morocco for culinary purposes [17]. Carvacrol is the major ingredient of Zataria Multiflora EO and induced apoptosis in 2D and 3D cell cultures of MDA-MB-231, MCF7, and T47D with selectivity and increased reactive oxygen species (ROS) generation, loss of mitochondrial membrane potential (ΔΨm), caspase 3 activation, and DNA damage [18]. Thymus vulgaris L. EO was also proapoptotic to MCF7 and MDA-MB-231 cells [6].

Nuclear factor-κB (NF-κB) is involved in tumor development by regulation of cell proliferation, apoptosis, and cell migration, and its activation is associated with both inflammation and development of cancer, processes that seem to be linked [19]; therefore, its influence by components can be used as a target. Justified by the use already made by the local population, research has shown that Cyphostemma juttae (Dinter & Gilg) Desc. EO decreased NF-κB activation with suppressive action on triple negative breast cancer cell lines (TNBCs) [20].

The inhibition effect of EO from Erythrina corallodendron L. (ECEO) seems to be mediated by the suppression of the epithelial-mesenchymal transition (EMT) process, implicated with metastasis in cancer progression. Another aspect that points to it being a possible good target for a new chemotherapeutic agent is that ECEO had greater cytotoxicity to breast cancer cells MDA-MB-231 and MCF7 than to normal human mammary epithelial cells (HMLEs). Although it was not as good as the positive drugs, it may qualify as an adjuvant drug [21].

MCF7 cells treated with frankincense EO (FCO), pine needle, and geranium activated the 5′-adenosine monophosphate-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signaling pathway, which controls cell growth, proliferation, and autophagy and is deregulated in cancer [22]. As a consequence, there was suppression of cell viability, proliferation, migration, and invasion activity. FCO was also effective in inhibiting tumor growth and inducing apoptosis in human BC mouse model [2].

Aquilaria spp. can provide agarwood, and its EO has proven to reduce the cell number of MCF7, suggesting an effect on cell death and attachment inhibition. Although there have not been any reports of its traditional use for cancer treatment, many reports show its use for inflammatory-associated diseases [23]. On the other hand, Boswellia sp. gum has proved to have anti-neoplastic effects and is very commonly used for aroma therapy. EO of B. sacra induced cell death in T47D, MCF7, and MDA-MB-231, and the EO hydrodistilled at 100°C was more potent than the one prepared at 78°C, which demonstrates the importance of the form of preparation in the effect of the EO [24].


3. Antitumoral activity of EOs and bioactive compounds

Terpenes (TPs) are usually part of EOs’ constituents. Terpenoids (TPNs) are a modified class of terpenes that can be classified according to the number of units of isoprene. Monoterpenes (MTs) are the TPNs with only 2 isoprene units and 10 carbon atoms, sesquiterpenes (STs) have 3 isoprene units and 15 carbon atoms, diterpenes have 4 isoprene units and 20 carbon atoms, triterpenes (TTs) have 6 isoprene units and 30 carbon atoms, and tetraterpenes have 8 isoprene units and 40 carbon atoms [25]. The biosynthesis of terpenoids is shown in Figure 1.

Figure 1.

Terpeneoids’ biosynthesis.

Sesquiterpenes (STs) are produced in plants in a way to interact with other plants and as a response to herbivores. These compounds are widely distributed, have been exploited in research for their phytomedicinal potential [26], and are associated with decreasing progression of cancer.

Many plants have demonstrated antiproliferative activity on MCF7 cells and have MT as a major constituent of their EO composition, such as the following : Schefflera heptaphylla (β-pinene) [27]; Heteropyxis dehniae (linalool) [28]; Schinus molle and Schinus terebinthifolius (α-phellandrene) [29]; Melaleuca alternifolia (terpinen-4-ol) [30]; Citrus limon, Citrus medica, and Citrus sinensis (limonene) [31]; and Cunila angustifolia (pulegone and isomenthol) [32], Satureja khuzistanica Jamzad (carvacrol) [33], Satureja intermedia C.A. Mey (γ-terpinene, thymol, and p-cymene) [34], Melaleuca armillaris (Sol Ex Gateau) (1,8-cineole) [35], Monodora myristica, Xylopia aethiopica, X. parviflora [36], Laurus nobilis, Origanum syriacum, O. vulgare, Salvia triloba [37], and berries of Schinus molle L. and S. terebinthifolius Raddi (more active) (α-phellandrene, β-phellandrene, α-terpineol, α-pinene, β-pinene, and ρ-cymene) [29].

Bisabolene isomers are the main constituents of opoponax (Commiphora guidotti); therefore, a ST named β-bisabolene and an alcoholic analogue, α-bisabolol, were tested for their in vitro and in vivo influence on BC. Only β-bisabolene exhibited selective cytotoxic activity for mouse cells MG1361 and human BC cells MCF7, MDA-MB-231, SKBR3, and BT474 with a 37.5% reduction of the growth of transplanted 4T1 mammary tumors [38].

EO of Myrcia splendens (Sw.) DC. (Myrtaceae) from Amazonian Ecuador has its anticancer activity in MCF7 attributed to α-bisabolol in its composition [39], and EO from leaves of Anaxagorea mainly composed of β-eudesmol, α-eudesmol, and β-bisabolene showed similar effect [40].

EO from leaves of Schinus terebinthifolius Raddi (Anacardiaceae) collected in Brazil, with germacrene D as one of the major compounds, and fractions were tested in vitro against MCF7. All of them had anticancer activity and that may be due to α- and β-pinene structures [41]. EO of S. molle made in Costa Rica was active in breast carcinoma EMT-6 cell line and also had beta-pinene and alpha-pinene as major components [42]. Similar results were not found in EO from leaves of Porcelia macrocarpa R. E. Fries (Annonaceae), with main compounds germacrene D and bicyclogermacrene, which did not have significant effect on human breast adenocarcinoma SKBr [43].

β-Elemene is the major active component of the EO from a traditional plant from China, Curcuma wenyujin Y.H. Chen et C. Ling, and showed significant cytotoxicity in multidrug-resistant cell line MCF7/adriamycin through inhibition of mTOR activity, related with cell proliferation and cancer, with the presence of autophagy. However, it only showed effects at high concentrations and the EO had problems regarding stability [44].

Different parts of the same plant can have different chemical constitution and biological activity. For example, the EO of Garcinia atroviridis Griff. ex T. Anders showed different results when different parts of plants were used. The essential oil from stem bark (EO-SB) had 79.8% of fatty acid including palmitoleic acid and palmitic acid, and the leaf oil (EO-L) had 86.3% of STs. While EO-SB did not induce cytotoxic effect, the EO-L stimulated the growth of BEAS-2B normal cells, but not in MCF7 cancerous cells, proving the medicinal effects of STs. But the best result was noticed when EO-L was associated with tamoxifen, which demonstrated better activity than the treatment with the drug alone [45]. The EO of Pallines spinose flower (F-PSEO) showed different composition than the leaf EO (L-PSEO). F-PSEO contained 96.39% of STs with 78.63% of the oil as oxygenated derivatives such as acorenone B, α-muurolol, and α-cadinol. The L-PSEO was composed of 51.60% of oxygenated STs and 34.06% of SQ hydrocarbons. F-PSEO had stronger anticancer results for MCF7 and MDA-MB-231 and both EOs induced a caspase-dependent and caspase-independent apoptosis and altered the levels of Bcl-2 and Bax proteins [46].

A component that can optimize the anticancer effects when combined with chemotherapy or reduce side effects of the current treatment is a target for many researches. Rhizoma curcumae is a plant known to possess activity against different types of cancer cells [47] and is common in Chinese medicine for the treatment of cancer [48]. Curcumol, a guaiane type ST lactone, is the major component of R. curcumaeis and, in combination with doxorubicin, made MDA-MB-231 cells more sensible to the action of doxorubicin through the activation of transcription factor NFAT1 and through the bind of the promoter region of miR-181b-2-3p, which is implicated in motility of BC [49] and less survival in breast cancer patients [50]. Curcumol also demonstrated in vivo suppress of tumor growth [49].

EO of Blepharocalyx salicifolius was cytotoxic against the MDA-MB-231 cell not by mechanisms related to apoptosis but by preventing cell metabolism reactions. Its main constituents identified were STs bicyclogermacrene, globulol, viridiflorol, γ-eudesmol, and α-eudesmol [51].

Leaves of Garcinia celebica L, popularly used in Malaysia and known as “manggishutan,” provide an ST-rich EO composed of α-copaene (61.25%), germacrene D (6.72%), and β-caryophyllene (5.85%) with antiproliferative action to MCF7 cells [52]. A similar result was found with the leaf of Phoebe bournei (Hemsl.) Yang, which is also composed mainly of STs such as α-copaene, α-muurolene, α-cadinene, and 1s-calamenene [53].

A ST isolated from the EO of Rhizoma curcumae named Furanodiene (FD) is associated with anticancer activities in various types of cancers in humans. FD also showed action on chemo-resistant breast cancer cells [54]. EO of R. curcumae and the main bioactive component FD were assessed on doxorubicin-resistant MCF7 cell line; although it showed inhibitory effects on cell viability it did not work on ABC transporters [47], which promote the efflux of chemotherapeutic compounds from cells leading to reduction of drug levels inside the cancer cells and insensitivity to the treatment associated with resistance [55]. Furthermore, FD induced apoptosis via intrinsic/extrinsic-dependent and NF-κB-independent pathways [54].

Multidrug-resistant human BC cells MCF7/ADR were treated with EO of Inula japonica (IJO) or its ST component isoalantolactone (ISO) or Angelicae dahuricae EO (ADO). IJO, ISO, and ADO may reverse the cancer cell by down-regulating ABCB1 expression [56]. This gene encodes a transporter that changes the phenotype of the cells into a multidrug resistance type associated with worse prognosis in BC patients [57].

EO of Lycopus lucidus Turcz. var. hirtus Regel was mainly composed of STs α-humulene, β-caryophyllene, and humulene epoxide II, which resulted in a significant dose-dependent inhibition of cell growth human BC cell lines MDA-MB-435S and ZR-75-30, possibly due to the presence of STs in its composition [58].

A primary alcohol named 2-phenylethanol was the main constituent in the EO of Magnolia virginiana, while in M. grandiflora oil sample the main compounds were ST alcohol (E,E)-farnesol (18%) and 2-phenylethanol (10%). Both EOs were active against MDA-MB231 cell [59]. Similar action was found with EO of Eryngium campestre and E. amethystinum from central Italy, rich in ST hydrocarbons like germacrene D, allo-aromadendrene, β-elemene, spathulenol, and ledol against human breast adenocarcinoma cells [60].

In the Amazon Rain Forest, climate changes seem to influence Iryanthera polyneura Ducke trees. EOs obtained from leaves collected in the rainy season were more active against MCF7. STs spathulenol, α-cadinol, and τ-muurolol were identified as the main compounds [61]. Some seasonal variation was also found in EO of Mentha species, M. arvensis, M. piperita, M. longifolia, and M. spicata, and they all stimulated the decrease of MCF7 proliferation. Their major compounds were MTs such as menthol, menthone, piperitenone oxide, and carvone, respectively [62].

STs represent 88.57% of all the compounds detected in Hedyosmum sprucei EO (Chloranthaceae), collected in the Amazonian region of Pastaza, which led to cytotoxic effects on MCF7 [63]. Similar effect was observed in STs from EO of Ballota undulata, B. saxatilis, B. nigra [64], Convolvulus althaeoides [65], Talauma gloriensis [66], Cedrelopsis grevei [67] and Feronia elephantum Correa [68].

Pinus roxburghii Sarg. is a Nepal pine used for skin injuries. Its needle EO can inhibit up to 70% of MCF7 cells due to high concentrations of STs such as (E)-caryophyllene and α-humulene and of MT alcohols terpinen-4-ol and α-terpineol [69]. P. sylvestris showed cytotoxic selectivity to ER-negative BC cells MDA-MB-231 compared to ER-positive cell line (MCF7) but its chemical composition was not elucidated [70].

Volatile oil from Saussurea lappa root (VOSL) showed better anti-breast cancer efficacy and lower side effects than its isolated STs named costunolide (Cos) and dehydrocostuslactone (Dehy), although when combined Cos and Dehy induced apoptosis with regulation of the c-Myc/p53 and AKT/14-3-3 signaling pathways in MCF7 cells or MDA-MB-231 [71].

Thymoquinone (TQ) is a MT and the main constituent of the EO from the seed of Nigella sativa. It can optimize chemotherapeutic agents and reduce its toxic side effects, proving to affect the modulation of signaling pathways and molecules with important participation in oncogenic processes such as initiation, progression, invasion, metastasis, and angiogenesis [1]. TQ encapsulated in poly(d,l-lactide-co-glycolide) nanoparticles inhibits the proliferation of MDA-MB-231cells [72], and same effect was obtained with TQ loaded with liposomes in MCF7 and T47D [73]. TQ derivates decreased the growth of MCF-7/Topo [74]. TQ improved the growth inhibition of reference drug doxorubicin in multidrug-resistant MCF-7/TOPO cells, which may be a good source for a booster in the treatment [75]. TQ also showed apoptotic effect in BC cell line (T47D) in combination with gemcitabine as well as alone [76].

TQ was not only active in BC cells but also in vivo by reduction of tumor cell growth, invasion, and migration. These actions seem to be related to the activation of peroxisome proliferator-activated receptor (PPAR)-γ, which acts to inhibit cell growth and proliferation. It also increases ROS, leading to the phosphorylation of p38, a mitogen-activated protein kinase (MAPK), which leads to an antiproliferative and proapoptotic efficacy of TQ in BC [77].

In breast tumor xenograft mouse model, TQ was able to reduce the tumor growth and act synergistically with doxorubicin with antiproliferative and proapoptotic effects [78]. Similar result was found with mice injected with triple negative BC (MDA-MB-231 and MDA-MB-436 cells), probably due to the inhibition of eukaryotic elongation factor 2 kinase (EEF2K) signaling [79], which downregulates steps in protein synthesis and increases solid tumor size in vivo [80]. On mice transplanted with breast cancer with EMT6/P cells, the synergic action of TQ and resveratrol decreased the tumor size and led to the cure of 60% animals with no liver or kidney toxicity. The combination also induced apoptosis in EMT6/p and human epithelial BC cell lines MCF7 and T47D [81]. In the xenograft mouse model, TQ increased expression of p-p38 protein in tumors, and led to a decrease in the XIAP, survivin, Bcl-xL, and Bcl-2 antiapoptotic proteins [78].

Eugenol (Eu), an oxygenated MT, is an important volatile constituent of clove EO mainly obtained from Syzygium, which has promising results in vitro for the prevention of the progression of BC, with alteration in cellular energy metabolism of MCF10A-ras [82]. For MCF-7 cell, there were cytotoxicity of cinnamon, thyme, chamomile, and jasmine EOs. MT eugenol seems to play an important role in cinnamon action [83].

EO rich in MT eucalyptol from Cinnamomum glanduliferum from Egypt and Nepeta menthoides from Iran inhibited respectively, MCF7 [84] and MCF7, T47D and MDA-MB-231 [85].

The EO from Hedychium spicatum from different regions of western Himalaya where collected and the samples from Almora, Binsar and Uttarakhand were rich in MT and ST and showed cytotoxicity action in MCF7 [86]. Similar effect was observed with EOs obtained from mint (Mentha spicata), ginger (Zingiber officinale), lemon (Citrus limonum), grapefruit (Citrus paradisi), jasmine (Jasminum grandiflora), lavender (Lavandula stoechas), chamomile (Anthemis nobilis), thyme (Thymus vulgaris), rose (Rosa centifolia) and cinnamon (C. zeylanicum) from a commercial source in China, composed by elements such as MTs limonene and menthol [83].

Protium heptaphyllum (Aubl.) EO was collected during 3 years and did not exhibit significant cytotoxicity against MCF7 cancer cells, with no change in caspase-3 and TNF-α levels. The major compounds were MT such as terpinolene and p-cymene-8-ol, and p-cymene. However, the EO had antimutagenic activity, which might provide a chemo-preventive effect [87].

The fruit of Angelica archangelica L. growing in Iceland provides MT-rich α-pinene EOs differing mainly in the absence or presence of the MT β-phellandrene. However the cytotoxic activity in Crl mouse-BC-cells was independent of the quantity of their main components [88].

The method of preparation affected the composition of EO from Pituranthos tortuosus (Desf.) Benth and Hook (Apiaceae). The EO was rich in MT and the major components of the sample prepared by hydrodistillation (HD) were MT β-myrcene, MT sabinene, phenylpropanoids trans-iso-elemicin and MT alcohol terpinen-4-ol. The mayor components from the sample prepared by simultaneous hydrodistillation solvent (n-pentane) (DE) were MTs terpinen-4-ol, sabinene, gamma-terpinene and beta-myrcene. And the mayor components from the sample prepared by conventional-volatile-solvent extraction (SE) were MT terpinen-4-ol, phenylpropanoid dillapiole, and MT allo-ocimene. The DE sample was the most potent against MCF7 [89].

Solanum erianthum leaf volatile oil demonstrated potent inhibitory activity against Hs 578T characterized by the abundance of MT α-terpinolene (17.8%), MT α-phellandrene (17.5%), MT ρ-cymene (15.7%), and MT β-pinene (11.7%) in the leaves [90].

The EO from Myristica fragrans (nutmeg) was composed of MT, oxygenated MT, SQ , phenolic ether, and phenylpropanoids, while Morinda citrifolia (mengkudu) had mostly carboxylic acids, esters, and isothiocyanate. Both Eos decreased MCF7 cells [91]. Similar effect was obtained with EO from leaves of Solanium spirale Roxb containing 48.10% of diterpene alcohol (E)-Phytol [92], with EO from leaf, stem, stem bark, and root of Uvariodendron angustifolium with the presence of citral (a mixture of terpenoids) [93] and with EO from Syzygium aromaticum, a source of TT [4].

Litsea cubeba, composed by 68.9% of MT citral, and Cinnamomum zeylanicum, mainly composed by (E)-cinnamaldehyde, also had inhibitory action on BC cells MCF7, T47D and MDA-MB-231 [94].

EO from Erigeron acris root showed higher antiproliferative activity for MCF7 and MDA-MBA-231 than E. annuus, which may be due to polyacetylenic compounds, matricaria and lachnophyllum ester [95], while Waldheimia glabra from the Himalayan Mountains, composed mainly of ST spathulenol and thujopsene, fatty alcohol 9-tetradecenol, MT α-thujone, santolina alcohol, and MT tertiary alcohols terpinen-4-ol only had mild action [96].

EO obtained from the seeds of onion Afro styrax lepidophyllus and garlic tree Scorodophloeus zenkeri are usually used as spices in Africa. It exhibited a strong inhibitory effect on MDA-MB 231. The predominant compound in both oils was the terpenoid 2,4,5,7-tetrathiaoctane [97]. EO of aerial parts, branches and leaves, of Glandora rosmarinifolia (Ten.) D.C. Thomas is composed mostly of aliphatic alkanes and diterpene hydrocarbons; it induces cell growth inhibition at triple negative-breast cancer-cell lines SUM 149 and MDA-MB-231 in part due to a pro-oxidant mechanism [5].


4. Optimization of the EOs’ use against BC

Nanoemulsions (NEs) can work as an ally to reduce some problems associated with Eos such as sensibility and lability. That is what happened with the use of Zataria multiflora EO loaded into chitosan (CS) nanoparticles. This combination improved the proliferation inhibition rate of BC cells as well as apoptosis, generation of ROS, trigger of mitochondrial membrane permeabilization and DNA damage, with high selectivity to human cancer cells of breast adenocarcinoma MCF7, T47D, and MDA-MB-231 [98].

Another study made with CS and N,N,N-trimethyl chitosan (TMC) also increased the toxicity of another EO from Ocimum gratissimum, when loaded with TNC nanoparticles on MDA-MB-231 BC cell lines [99]. A similar result was found using Cyperus articulatus EO loaded with CS nanoparticles [100].

Nigella sativa L. has been used in traditional medicine for about 1400 years and it grows in countries bordering the Mediterranean Sea and India [101]. Its EO has properties such as anti-inflammatory and anticancer. N. sativa-EO-NE increased the apoptosis of MCF7 [102].

Mitomycin C (MTC) was solubilized in NEs of EO from ginger (EOG) and from frankincense, which was shown to increase the toxicity for MCF7 cells when compared with the use of MMC alone. EOG had the strongest apoptotic effect [103]. The same effect was seen when MTC was combined with chamomile NE oil [104].

Sandal wood EO (SEO), extracted from Santalum trees, was encapsulated into liposomes composed of 15% SEO, 78.5% water, 4% enzyme modified lecithin, and 2.5% polysorbate. This combination provoked DNA damage and cytotoxicity and genotoxicity against MCF7 cells [105].


5. EOs as an alternative for side effects reduction during BC treatment

Chemotherapy-induced nausea and emesis are one of the most common problems in BC patients and they can be inappropriately managed due to low affordability of new medications [106]. Women suffering from BC received 5-day aroma therapy treatment using either ginger EO or a placebo. Nausea score was significantly lower after ginger EO inhalation but was not sustained for the overall treatment effect. Overall, the EO improved health-related quality of life [107].

Symptoms of urogenital atrophy (UA) are common in BC survivors [108]. The cause is due to systemic treatments as a side effect of endocrine therapies and topical estrogen is usually used to reduce the symptoms. Other alternatives are being sought and could be valid to improve life quality of the patients with BC. EO of Cymbopogon martini and Pelargonium graveolens affected the cell grown in hormone-dependent MCF7 and hormone-independent MDA-MB-231 cell lines with pronounced estrogenicity, but clinical trials are necessary to better understand these effects [109].

Reaction on the skin can happen in BC patients under radiotherapy treatment. Twenty four patients received an EO mixture with 32.5% of jojoba (Simmondsia chinensis), 30% Aloe vera (Aloe barbadenisis), 10% of Tamanu (Calophyllum inophyllum), 10% primrose Oenothera biennis), 5% frankincense (Boswellia carteri), 5% geranium (Pelargonium graveolens), 5% lavender (Lavandula angustifolia), and 2.5% helichrysum (Helichrysum angustifolium) this EO mixture had a similar result as a medication used for treating this side effect and therefore can be used as an alternative treatment [110].


6. Unsatisfactory EOs results for BC

Some EOs used in research were not able to have satisfactory in vitro anticancer effects on MCF7 as EO from Sideritis perfoliata, Satureja thymbra, Salvia officinalis, Laurus nobilis, Pistacia palaestina [111], Nepeta cataria L. [112], Nectandra leucantha [113], Laurus nobilis L, Origanum syriacum L, Origanum vulgare L, Salvia triloba L. [37], Salvia officinalis [114], grapefruit (Citrus paradisi), ginger (Zingiber officinale) [83], and Anemopsis californica [115].

Origanum vulgare EO, composed mostly of 4-terpineol, induced cell proliferation of MCF7, although at the concentration of 50 mg/mL opposite effect was found, but still with minor effect when compared to the result in other cancer cells [116]. Aloysia citriodora, Boswellia sacra, Boswellia serrata, Cistus ladanifer, Citrus × aurantium, Citrus limon, Citrus sinensis, Cymbopogon citratus, Foeniculum vulgar, Illicium verum, Satureja montana, Syzygium aromaticum, Thymus capitatus, and Thymus vulgaris presented minor effects in MCF7, T47D, and MDA-MB-231 [94].

EO of Semenovia suffruticosa grown in Kerman, Iran, induced cell death in MCF7, but it also had the same effect on normal cell line [117]. EO from the leaves of Solanum macranthum did not show anticancer properties in Hs578T [90].

This information is helpful to elucidate some effects of EOs that are used by the population. Some EOs may not have any effect for BC or can even help stimulate BC cells or have toxic action. Due to this, it is important to determinate if they are safe for common use. Furthermore, it is worth mentioning that the results show unsatisfactory effects in regard to concentrations used, which does not prevent the use of these EOs in other researches with different outcomes.


7. Conclusions

Sesquiterpenes and monoterpenes are part of the main components of essential oils, some of them already being isolated and with actions described, although it is important to establish the force of the use of multiple compounds together.

A large number of essential oils from different plants have been described in the literature with promising in vitro effect in a variety of breast cancer cells and even with in vivo effects in murine model; it is important to continue this research and take it to the next level with clinical trials.

The articles found in the literature and their results encourage the use of essential oils. The importance of plant research and the production of these oils demonstrated the difference they can make as a supporting anticancer agent or as a reducer of the side effects of breast cancer, which shows its power in the fight against breast cancer.



The authors would like to thank Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Coordination for the Improvement of Higher Education Personnel), Brazil (CAPES) [Finance Code 001] and Instituto Oswaldo Cruz for financial support.


Conflict of interest

The authors declare no conflict of interest.


  1. 1. Shanmugam MK, Arfuso F, Kumar AP, Wang L, Goh BC, Ahn KS, et al. Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa, Linn. Pharmacological Research. 2018;129:357-364. DOI: 10.1016/j.phrs.2017.11.023
  2. 2. Ren P, Ren X, Cheng L, Xu L. Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK/mTOR pathway in breast cancer. Oncology Reports. 2018;39:129-137. DOI: 10.3892/or.2017.6067
  3. 3. Bagheri SM, Asl AA, Shams A, Mirghanizadeh-Bafghi SA, Hafizibarjin Z. Evaluation of cytotoxicity effects of oleo-gum-resin and its essential oil of ferula Assa-foetida and ferulic acid on 4T1 breast cancer cells. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical & Paediatric Oncology. 2017;38:116. DOI: 10.4103/ijmpo.ijmpo_60_16
  4. 4. Kumar PS, Febriyanti RM, Sofyan FF, Luftimas DE, Abdulah R. Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines. Pharmacognosy Research. 2014;6:350-354. DOI: 10.4103/0974-8490.138291
  5. 5. Poma P, Labbozzetta M, Notarbartolo M, Bruno M, Maggio A, Rosselli S, et al. Chemical composition, in vitro antitumor and pro-oxidant activities of Glandora rosmarinifolia (Boraginaceae) essential oil. PLoS One. 2018;13:e0196947. DOI: 10.1371/journal.pone.0196947
  6. 6. Kubatka P, Uramova S, Kello M, Kajo K, Samec M, Jasek K, et al. Zubor P, Anticancer activities of Thymus vulgaris l. in experimental breast carcinoma in vivo and in vitro. International Journal of Molecular Sciences. 2019;20:1749. DOI: 10.3390/ijms20071749
  7. 7. Ghasemian A, Al-Marzoqi AH, Mostafavi SK, Alghanimi YK, Teimouri M. Chemical composition and antimicrobial and cytotoxic activities of Foeniculum vulgare mill essential oils. Journal of Gastrointestinal Cancer. 2020;51:260-266. DOI: 10.1007/s12029-019-00241-w
  8. 8. Wong RS. Apoptosis in cancer: From pathogenesis to treatment. Journal of Experimental & Clinical Cancer Research. 2011;30:87. DOI: 10.1186/1756-9966-30-87
  9. 9. Akhbari M, Kord R, Jafari Nodooshan S, Hamedi S. Analysis and evaluation of the antimicrobial and anticancer activities of the essential oil isolated from Foeniculum vulgare from Hamedan, Iran. Natural Product Research. 2019;33:1629-1632. DOI: 10.1080/14786419.2017.1423310
  10. 10. Sharopov F, Valiev A, Satyal P, Gulmurodov I, Yusufi S, Setzer WN, et al. Cytotoxicity of the essential oil of fennel (Foeniculum vulgare) from Tajikistan. Food. 2017;6:73. DOI: 10.3390/foods6090073
  11. 11. Jamali T, Kavoosi G, Ardestani SK. In-vitro and in-vivo anti-breast cancer activity of OEO (Oliveria decumbens vent essential oil) through promoting the apoptosis and immunomodulatory effects. Journal of Ethnopharmacology. 2020;2(48):112313. DOI: 10.1016/j.jep.2019.112313
  12. 12. Jamali T, Kavoosi G, Safavi M, Ardestani SK. In-vitro evaluation of apoptotic effect of OEO and thymol in 2D and 3D cell cultures and the study of their interaction mode with DNA. Scientific Reports. 2018;8:1-19. DOI: 10.1038/s41 598-018-34055-w
  13. 13. Saeidi M, Asili J, Emami SA, Moshtaghi N, Malekzadeh-Shafaroudi S. Comparative volatile composition, antioxidant and cytotoxic evaluation of the essential oil of Zhumeriamajdae from south of Iran. Iranian Journal of Basic Medical Sciences. 2019;22:80-85. DOI: 10.22038/ijbms.2018.20829.5418
  14. 14. Gómez CE, Carreño AA, Ishiwara DP, Martínez ES, López JM, Hernández NP, et al. Decatropis bicolor (Zucc.) Radlk essential oil induces apoptosis of the MDA-MB-231 breast cancer cell line. BMC Complementary and Alternative Medicine. 2016;16:266. DOI: 10.1186/s12906-016-1136-7
  15. 15. Manaharan T, Thirugnanasampandan R, Jayakumar R, Kanthimathi MS, Ramya G, Ramnath MG. Purified essential oil from Ocimum sanctum Linn. Triggers the apoptotic mechanism in human breast cancer cells. Pharmacognos Magazine. 2016;12:327-331. DOI: 10.4103/0973-1296.185738
  16. 16. Buhagiar JA, Podesta MT, Wilson AP, Micallef MJ, Ali S. The induction of apoptosis in human melanoma, breast and ovarian cancer cell lines using an essential oil extract from the conifer Tetraclinis articulata. Anticancer Research. 1999;19:5435-5443
  17. 17. Harassi Y, Tilaoui M, Idir A, Frédéric J, Baudino S, Ajouaoi S, et al. Phytochemical analysis, cytotoxic and antioxidant activities of Myrtus communis essential oil from Morocco. Journal of Complementary and Integrative Medicine. 2019;16:1-8. DOI: 10.1515/jcim-2018-0100
  18. 18. Salehi F, Behboudi H, Kavoosi G, Ardestani SK. Monitoring ZEO apoptotic potential in 2D and 3D cell cultures and associated spectroscopic evidence on mode of interaction with DNA. Scientific Reports. 2017;7:1-4. DOI: 10.10 38/s41598-017-02633-z
  19. 19. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: From innocent bystander to major culprit. Nature Reviews Cancer. 2002;2:301-310. DOI: 10.103 8/nrc780
  20. 20. Zito P, Labbozzetta M, Notarbartolo M, Sajeva M, Poma P. Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells. PLoS One. 2019;14:e0214594. DOI: 10.1371/journal.pone.0214594
  21. 21. Xing X, Ma JH, Fu Y, Zhao H, Ye XX, Han Z, et al. Essential oil extracted from Erythrina corallodendron L. leaves inhibits the proliferation, migration, and invasion of breast cancer cells. Medicine. 2019;98:e17009. DOI: 10.1097/MD.0000000000017009
  22. 22. Chapuis N, Tamburini J, Green AS, Willems L, Bardet V, Park S, et al. Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia. 2010;24:1686-1699. DOI: 10.1038/leu.2010.170
  23. 23. Hashim YZ, Phirdaous A, Azura A. Screening of anticancer activity from agarwood essential oil. Pharmacognosy Research. 2014;6:191-194. DOI: 1.4103/0974 -8490.13259
  24. 24. Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, et al. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complementary and Alternative Medicine. 2011;11:129. DOI: 10 .1186/1472-6882-11-129
  25. 25. Perveen S. Introductory chapter: Terpenes and terpenoids. In: Terpenes and Terpenoids. Rijeka: IntechOpen; 2018. DOI: 10.5772/intechopen.79683
  26. 26. Silva WMC, Andersen JL, Holanda MT, Walter MEMT, Brigido MM, Stadler PF, et al. Exploring plant sesquiterpene diversity by generating chemical networks. PRO. 2019;7:240. DOI: 10.20944/preprints201903.0015.1
  27. 27. Li YL, Yeung CM, Chiu LC, Cen YZ, Ooi VE. Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Schefflera heptaphylla. Phytotherapy Research. 2009;23:140-142. DOI: 10.1002/ptr.2567
  28. 28. Sibanda S, Chigwada G, Poole M, Gwebu ET, Noletto JA, Schmidt JM, et al. Composition and bioactivity of the leaf essential oil of Heteropyxis dehniae from Zimbabwe. Journal of Ethnopharmacology. 2004;92(1):07-111. DOI: 10.1016/j.jep.2004.02.010
  29. 29. Bendaoud H, Romdhane M, Souchard JP, Cazaux S, Bouajila J. Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius Raddi berries essential oils. Journal of Food Science. 2010;75:C466-C472. DOI: 10.1111/j.1750-3841.2010.01711.x
  30. 30. Liu X, Zu Y, Fu Y, Yao L, Gu C, Wang W, et al. Antimicrobial activity and cytotoxicity towards cancer cells of Melaleuca alternifolia (tea tree) oil. European Food Research and Technology. 2009;229:247-253. DOI: 10.1007/s002 17-009-1057-5
  31. 31. Monajemi R, Oryan S, Haeri RS, Ghanadi AR, Jafarian DA. Cytotoxic effects of essential oils of some Iranian citrus peels. Iranian Journal of Pharmaceutical Research. 2005;4:183-187. DOI: 10.22037/ijpr.2010.65
  32. 32. De Sousa MH, Morgan J, Cesca K, Flach A, Moura N. Cytotoxic activity of Cunila angustifolia Benth essential oil. Chemistry & Biodiversity. 2020;17:e190, 065. DOI: 10.1002/cbdv.201900656
  33. 33. Yousefzadi M, Riahi-Madvar A, Hadian J, Rezaee F, Rafiee R, Biniaz M. Toxicity of essential oil of Satureja khuzistanica: In vitro cytotoxicity and anti-microbial activity. Journal of Immunotoxicology. 2014;11:50-55. DOI: 10.3109/1547691X.2013.789939
  34. 34. Sharifi-Rad J, Sharifi-Rad M, Hoseini-Alfatemi SM, Iriti M, Sharifi-Rad M, Sharifi-Rad M. Composition, cytotoxic and antimicrobial activities of Satureja intermedia C.A. Mey essential oil. International Journal of Molecular Sciences. 2015;16:17812-17825. DOI: 10.3390/ijms160817812
  35. 35. Chabir N, Romdhane M, Valentin A, Moukarzel B, Marzoug HN, Brahim NB, et al. Chemical study and antimalarial, antioxidant, and anticancer activities of Melaleuca armillaris (sol ex gateau) Sm essential oil. Journal of Medicinal Food. 2011;14:1383-1388. DOI: 10.1089/jmf.2010.0168
  36. 36. Bakarnga-Via I, Hzounda JB, Fokou PV, Tchokouaha LR, Gary-Bobo M, Gallud A, et al. Composition and cytotoxic activity of essential oils from Xylopia aethiopica (Dunal) A. rich, Xylopia parviflora (A. rich) Benth. and Monodora myristica (Gaertn) growing in Chad and Cameroon. BMC Complementary and Alternative Medicine. 2014;14:125. DOI: 10.1186/1472-6882-14-125
  37. 37. Al-Kalaldeh JZ, Abu-Dahab R, Afifi FU. Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells. Nutrition Research. 2010;30:271-278. DOI: 10.1016/j.nutres.2010.04.001
  38. 38. Yeo SK, Ali AY, Hayward OA, Turnham D, Jackson T, Bowen ID, et al. β-Bisabolene, a sesquiterpene from the essential oil extract of opoponax (Commiphora guidottii), exhibits cytotoxicity in breast cancer cell lines. Phytotherapy Research. 2016;30:418-425. DOI: 10.1002/ptr.5543
  39. 39. Scalvenzi L, Grandini A, Spagnoletti A, Tacchini M, Neill D, Ballesteros JL, et al. Myrciasplendens (Sw.) DC. (syn. M. fallax (Rich.) DC.) (Myrtaceae)essential oil from Amazonian Ecuador: A chemical characterization and bioactivity profile. Molecules. 2017;22:1163. DOI: 10.3390/m olecules22071163
  40. 40. De Alencar DC, Pinheiro ML, Pereira JL, de Carvalho JE, Campos FR, Serain AF, et al. Chemical composition of the essential oil from the leaves of Anaxagorea brevipes (Annonaceae) and evaluation of its bioactivity. Natural Product Research. 2016;30:1088-1092. DOI: 10.1080/14786419.2015.1101103
  41. 41. Santana JS, Sartorelli P, Guadagnin RC, Matsuo AL, Figueiredo CR, Soares MG, et al. Essential oils from Schinus terebinthifolius leaves—Chemical composition and in vitro cytotoxicity evaluation. Pharmaceutical Biology. 2012;50:1248-1253. DOI: 10.3109/13880209.2012.666880
  42. 42. Díaz C, Quesada S, Brenes O, Aguilar G, Cicció JF. Chemical composition of Schinus molle essential oil and its cytotoxic activity on tumour cell lines. Natural Product Research. 2008;22:1521-1534. DOI: 10.10 80/1478641 0701848154
  43. 43. Da Silva EB, Matsuo AL, Figueiredo CR, Chaves MH, Sartorelli P, Lago JH. Chemical constituents and cytotoxic evaluation of essential oils from leaves of Porcelia macrocarpa (Annonaceae). Natural Product Communications. 2013;8:277-279. DOI: 10.1177/1934578x1300800237
  44. 44. Ding XF, Shen M, Xu LY, Dong JH, Chen G. 13, 14-bis (cis-3, 5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cells. Oncology Letters. 2013;5:1554-1558. DOI: 10.3892/ol.2013.1213
  45. 45. Tan WN, Lim JQ , Afiqah F, Nik Mohamed Kamal NN, Abdul Aziz FA, Tong WY, et al. Chemical composition and cytotoxic activity of Garcinia atroviridis Griff. ex T. Anders. essential oils in combination with tamoxifen. Natural Product Research. 2018;32:854-858. DOI: 10.1080/14786419.2 017.1361951
  46. 46. Saleh AM, Al-Qudah MA, Nasr A, Rizvi SA, Borai A, Daghistani M. Comprehensive analysis of the chemical composition and in vitro cytotoxic mechanisms of Pallines spinosa flower and leaf essential oils against breast cancer cells. Cellular Physiology and Biochemistry. 2017;42:2043-2065. DOI: 10.1159/000479900
  47. 47. Zhong Z, Yu H, Wang S, Wang Y, Cui L. Anti-cancer effects of Rhizoma curcumae against doxorubicin-resistant breast cancer cells. Chinese Medicine. 2018;13:44. DOI: 10.1186/s13020-018-0203-z
  48. 48. Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, Wang YT. Anti-cancer properties of terpenoids isolated from Rhizoma curcumae—A review. Jornal of Ethnopharmacology. 2012;143:406-411. DOI: 10.1016/j.jep.2012.07.009
  49. 49. Zeng C, Fan D, Xu Y, Li X, Yuan J, Yang Q , et al. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis. Biochemical Pharmacology. 2020;174:113795. DOI: 10.1016/j.bcp.2020.113795
  50. 50. Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nature Communications. 2014;5(5):671. DOI: 10.1038/ncomms6671
  51. 51. Furtado FB, Borges BC, Teixeira TL, Garces HG, Almeida Junior LD, Alves FC, et al. Chemical composition and bioactivity of essential oil from Blepharocalyx salicifolius. International Journal of Molecular Sciences. 2018;19:33. DOI: 10.3390/ijms19010033
  52. 52. Tan WN, Tan ZH, Zulkifli NI, Nik Mohamed Kamal NN, Rozman NA, Tong WY, et al. Sesquiterpenes rich essential oil from Garcinia celebica L. and its cytotoxic and antimicrobial activities. Natural Product Research. 2019;17:1-5. DOI: 10.1080/14786419.2019.1569012
  53. 53. Ding W, Liping N, Xing H, Wei Z, Zhoua Q , Nong R, et al. Essential oil extracted from leaf of Phoebe bournei (Hemsl.) yang: Chemical constituents, antitumor, antibacterial, hypoglycemic activities. Natural Product Research. 2018;23:1-4. DOI: 10.1080/14786419.2018.1542393
  54. 54. Zhong ZF, Yu HB, Wang CM, Qiang WA, Wang SP, Zhang JM, et al. Furanodiene induces extrinsic and intrinsic apoptosis in doxorubicin-resistant MCF-7 breast cancer cells via NF-κB-independent mechanism. Frontiers in Pharmacology. 2017;8:648. DOI: 10.3389/fphar.2017.00 648
  55. 55. Gottesman MM. Mechanisms of cancer drug resistance. Annual Review of Medicine. 2002;53:615-627. DOI: 10.1146/ 929
  56. 56. Wu M, Li T, Chen L, Peng S, Liao W, Bai R, et al. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms. Journal of Ethnopharmacology. 2016;180:18-27. DOI: 10.1016/j.jep.2016.01.015
  57. 57. Delou JMA, Vignal GM, Índio-do-Brasil V, Accioly MTS, da Silva TSL, Piranda DN, et al. Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis. Breast Cancer (Dove Med Press). 2017;9:415-428. DOI: 10.2147/BCT T.S131284
  58. 58. Yu JQ , Lei JC, Zhang XQ , Yu HD, Tian DZ, Liao ZX, et al. Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel. Food Chemistry. 2011;126:1593-1598. DOI: 10.1016/ dchem.2010.12.027
  59. 59. Farag MA, Al-Mahdy DA. Comparative study of the chemical composition and biological activities of Magnolia grandiflora and Magnolia virginiana flower essential oils. Natural Product Research. 2013;27:1091-1097. DOI: 10.1080/14 786419. 2012.696256
  60. 60. Cianfaglione K, Blomme EE, Quassinti L, Bramucci M, Lupidi G, Dall’Acqua S, et al. Cytotoxic essential oils from Eryngium campestre and Eryngium amethystinum (Apiaceae) growing in central Italy. Chemistry & Biodiversity. 2017;14:e1700096. DOI: 10.1002/cbdv.201700096
  61. 61. Martins ER, Díaz IE, Paciencia ML, Fana SA, Morais D, Eberlin MN, et al. Interference of seasonal variation on the antimicrobial and cytotoxic activities of the essential oils from the leaves of Iryanthera polyneura in the Amazon rain forest. Chemistry & Biodiversity. 2019;16:e19003. DOI: 10.1002/cbdv.20190037 4
  62. 62. Hussain AI, Anwar F, Nigam PS, Ashraf M, Gilani AH. Seasonal variation in content, chemical composition and antimicrobial and cytotoxic activities of essential oils from four Mentha species. Journal of the Science of Food and Agriculture. 2010;90:1827-1836. DOI: 10.1002/jsfa.4021
  63. 63. Guerrini A, Sacchetti G, Grandini A, Spagnoletti A, Asanza M, Scalvenzi L. Cytotoxic effect and TLC bioautography-guided approach to detect health properties of amazonian Hedyosmum sprucei essential oil. Evidence-based Complementary and Alternative Medicine. 2016:1-8. DOI: 10.1155/2016/163834 2
  64. 64. Rigano D, Marrelli M, Formisano C, Menichini F, Senatore F, Bruno M, et al. Phytochemical profile of three Ballota species essential oils and evaluation of the effects on human cancer cells. Natural Product Research. 2017;31:436-444. DOI: 10.1080/14786419.2016.1185722
  65. 65. Hassine M, Zardi-Berguaoui A, Znati M, Flamini G, Ben Jannet H, Hamza MA. Chemical composition, antibacterial and cytotoxic activities of the essential oil from the flowers of tunisian Convolvulus althaeoides L. Natural Product Research. 2014;28:769-775. DOI: 10.1080/14786419.2013.87947
  66. 66. Haber WA, Agius BR, Stokes SL, Setzer WN. Bioactivity and chemical composition of the leaf essential oil of Talauma gloriensis Pittier (Magnoliaceae) from Monteverde, Costa Rica. Records of Natural Products. 2008;2:1-5
  67. 67. Afoulous S, Ferhout H, Raoelison EG, Valentin A, Moukarzel B, Couderc F, et al. Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei. Food and Chemical Toxicology. 2013;56:352-362. DOI: 10.1016/j.fct.2013.02.008
  68. 68. Thirugnanasampandan R, David D. In vitro antioxidant and cytotoxic activities of essential oil of Feronia elephantum Correa. Asian Pacific Journal of Tropical Biomedicine. 2014;4:290-293. DOI: 10.12980/APJTB.4.2014B878
  69. 69. Satyal P, Paudel P, Raut J, Deo A, Dosoky NS, Setzer WN. Volatile constituents of Pinus roxburghii from Nepal. Pharmacognosy Research. 2013;5:43-48. DOI: 10.4103/0974-8490.105650
  70. 70. Hoai NT, Duc HV, Do Thi Thao AO, Raal A. Selectivity of Pinus sylvestris extract and essential oil to estrogen-insensitive breast cancer cells Pinus sylvestris against cancer cancer cells. Pharmacognosy Magazine. 2015;11:S290–S295. DOI: 10.4103/0973-1296.166052
  71. 71. Peng Z, Wang Y, Fan J, Lin X, Liu C, Xu Y, et al. Costunolide and dehydrocostus lactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway. Scientific Reports. 2017;7:41254. DOI: 10.1038/srep41254
  72. 72. Ganea GM, Fakayode SO, Losso JN, Van Nostrum CF, Sabliov CM, Warner IM. Delivery of phytochemical thymoquinone using molecular micelle modified poly (d,l lactide-co-glycolide) (PLGA) nanoparticles. Nanotechnology. 2010;21:285104. DOI: 10.1088/0957-4484/21/28/285104
  73. 73. Odeh F, Ismail SI, Abu-Dahab R, Mahmoud IS, Al BA. Thymoquinone in liposomes: A study of loading efficiency and biological activity towards breast cancer. Drug Delivery. 2012;19:371-377. DOI: 10.3109/10717544.2012.727500
  74. 74. Effenberger K, Breyer S, Schobert R. Terpene conjugates of the Nigella sativa seed-oil constituent thymoquinone with enhanced efficacy in cancer cells. Chemistry & Biodiversity. 2010;7:129-139. DOI: 10.1002/cbdv.200900328
  75. 75. Effenberger-Neidnicht K, Schobert R. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemotherapy and Pharmacology. 2011;67:867-874. DOI: 10.1007/s00280-010-1386-x
  76. 76. Bashmail HA, Alamoudi AA, Noorwali A, Hegazy GA, AJabnoor G, Choudhry H, et al. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities. Scientific Reports. 2018;8:1-11. DOI: 10.1038/s41598-018-30046-z
  77. 77. Woo CC, Loo SY, Gee V, Yap CW, Sethi G, Kumar AP, et al. Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway. Biochemical Pharmacology. 2011;82:464-475. DOI: 10.1016/j.bcp.2011.05.030
  78. 78. Woo CC, Hsu A, Kumar AP, Sethi G, Tan KH. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: The role of p38 MAPK and ROS. PloS One. 2013;8:e75356. DOI: 10.1371/journal. pone.0075356
  79. 79. Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, et al. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Research and Treatment. 2018;171:593-605. DOI: 10.1007/s10549-018-4847-2
  80. 80. Wang X, Xie J, Proud CG. Eukaryotic elongation factor 2 kinase (eEF2K) in cancer. Cancers (Basel). 2017;9:162. DOI: 10.3390/cancers9120162
  81. 81. Alobaedi OH, Talib WH, Basheti IA. Antitumor effect of thymoquinone combined with resveratrol on mice transplanted with breast cancer. Asian Pacific Journal of Tropical Medicine. 2017;10:400-408. DOI: 10.1016/j.apjtm.2017.03.026
  82. 82. Yan X, Zhang G, Bie F, Lv Y, Ma Y, Ma M, et al. Eugenol inhibits oxidative phosphorylation and fatty acid oxidation via downregulation of c-Myc/PGC-1β/ERRα signaling pathway in MCF10A-ras cells. Scientific Reports. 2017;7:12920. DOI: 10.1038/s41598-017-13505-x
  83. 83. Zu Y, Yu H, Liang L, Fu Y, Efferth T, Liu X, et al. Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. Molecules. 2010;15:3200-3210. DOI: 10.3390/molecules15053200
  84. 84. Taha AM, Eldahshan OA. Chemical characteristics, antimicrobial, and cytotoxic activities of the essential oil of egyptian Cinnamomum glanduliferum bark. Chemistry & Biodiversity. 2017;14:e1600443. DOI: 10.1002/cbdv.201600443
  85. 85. Kahkeshani N, Hadjiakhoondi A, Navidpour L, Akbarzadeh T, Safavi M, Karimpour-Razkenari E, et al. Chemodiversity of Nepeta menthoides Boiss. & Bohse. essential oil from Iran and antimicrobial, acetylcholinesterase inhibitory and cytotoxic properties of 1,8-cineole chemotype. Natural Product Research. 2018;32:2745-2748. DOI: 10.1080/14786419.2017.1378202
  86. 86. Mishra T, Pal M, Meena S, Datta D, Dixit P, Kumar A, et al. Composition and in vitro cytotoxic activities of essential oil of Hedychium spicatum from different geographical regions of western Himalaya by principal components analysis. Natural Product Research. 2015;30:1-4. DOI: 10.1080/14786419.2015.1049176
  87. 87. De Lima EM, Cazelli DS, Pinto FE, Mazuco RA, Kalil IC, Lenz D, et al. Essential oil from the resin of Protium heptaphyllum: Chemical composition, cytotoxicity, antimicrobial activity, and antimutagenicity. Pharmacognosy Magazine. 2016;12:S42-S46. DOI: 10.4103/0973-1296.176113
  88. 88. Sigurdsson S, Ögmundsdóttir HM, Gudbjarnason S. The cytotoxic effect of two chemotypes of essential oils from the fruits of Angelica archangelica L. Anticancer Research. 2005;25:1877-1880
  89. 89. Abdallah HM, Ezzat SM. Effect of the method of preparation on the composition and cytotoxic activity of the essential oil of Pituranthos tortuosus. Zeitschrift fur Naturforschung. C. Journal of Biosciences. 2011;66:143-148. DOI: 10.1515/znc-2011-3-408
  90. 90. Essien EE, Ogunwande IA, Setzer WN, Ekundayo O. Chemical composition, antimicrobial, and cytotoxicity studies on S. erianthum and S. macranthum essential oils. Pharmaceutical Biology. 2012;50:474-480. DOI: 10.3109 /13880209.2011.614623
  91. 91. Piaru SP, Mahmud R, Abdul Majid AM, Ismail S, Man CN. Chemical composition, antioxidant and cytotoxicity activities of the essential oils of Myristica fragrans and Morinda citrifolia. Journal of the Science of Food and Agriculture. 2012;92:593-597. DOI: 10.1002/jsfa.4613
  92. 92. Keawsa-Ard S, Liawruangrath B, Liawruangrath S, Teerawutgulrag A, Pyne SG. Chemical constituents and antioxidant and biological activities of the essential oil from leaves of Solanum spirale. Natural Product Communications. 2012;7:955-958. DOI: 10.1177/1934578X1200700740
  93. 93. Noudogbessi JP, Gary-Bobo M, Adomou A, Adjalian E, Alitonou GA, Avlessi F, et al. Comparative chemical study and cytotoxic activity of Uvariodendron angustifolium essential oils from Benin. Natural Product Communications. 2014;9:261-264. DOI: 10.1177/1934578X1400900232
  94. 94. Najar B, Shortrede JE, Pistelli L, Buhagiar J. Chemical composition and in vitro cytotoxic screening of sixteen commercial essential oils on five cancer cell lines. Chemistry & Biodiversity. 2020;17:e1900478. DOI: 10.1002/cbdv.201900478
  95. 95. Nazaruk J, Karna E, Wieczorek P, Sacha P, Tryniszewska E. In vitro antiproliferative and antifungal activity of essential oils from Erigeron acris L. and Erigeron annuus (L.) Pers. Zeitschrift fur Naturforschung. C. Journal of Biosciences. 2010;65:642-646. DOI: 10.1515/znc-2010-11-1202
  96. 96. Manzo A, Musso L, Panseri S, Iriti M, Dallavalle S, Catalano E, et al. Screening of the chemical composition and bioactivity of Waldheimia glabra (Decne.) Regel essential oil. Journal of the Science of Food and Agriculture. 2016;96:3195-3201. DOI: 10.1002/jsfa.7499
  97. 97. Fogang HP, Maggi F, Tapondjou LA, Womeni HM, Papa F, Quassinti L, et al. In vitro biological activities of seed essential oils from the camerooni an spices Afrostyrax lepidophyllus mild br. and Scorodophloeus zenkeri harms rich in sulfur-containing compounds. Chemistry & Biodiversity. 2014;11:161-169. DOI: 10.1002/cbdv.201300237
  98. 98. Salehi F, Behboudi H, Kavoosi G, Ardestani SK. Incorporation of Zataria multiflora essential oil into chitosan biopolymer nanoparticles: A nanoemulsion based delivery system to improve the in-vitro efficacy, stability and anticancer activity of ZEO against breast cancer cells. International Journal of Biological Macromolecules. 2020;143:382-392. DOI: 10.1016/j. ijbiomac.2019.12.058
  99. 99. Onyebuchi C, Kavaz D. Chitosan and n,n,n-trimethyl chitosan nanoparticle encapsulation of Ocimum gratissimum essential oil: Optimised synthesis,in vitro release and bioactivity. International Journal of Nanomedicine. 2019;14:7707-7727. DOI: 10.2147/IJN.S220202
  100. 100. Kavaz D, Idris M, Onyebuchi C. Physiochemical characterization, antioxidative, anticancer cells proliferation and food pathogens antibacterial activity of chitosan nanoparticles loaded with Cyperus articulatus rhizome essential oils. International Journal of Biological Macromolecules. 2019;123:837-845. DOI: 10.1016/j.ijbiomac.2018.11.177
  101. 101. Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: A promising anti-cancer drug from natural sources. The International Journal of Biochemistry & Cell Biology. 2006;38:1249-1253. DOI: 10.1016/j.biocel.2005.10.009
  102. 102. Periasamy VS, Athinarayanan J, Alshatwi AA. Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells. Ultrasonics Sonochemistry. 2016;31:449-455. DOI: 10.1016/j.ultsonch.2016.01.035
  103. 103. Al-Otaibi WA, Alkhatib MH, Wali AN. Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations. Biomedicine & Pharmacotherapy. 2018;106:946-955. DOI: 10.1016/j.biopha.2018.07.041
  104. 104. Al-Otaibi WA, Alkhatib MH, Wali AN. Evaluation of antitumor activity and hepatoprotective effect of mitomycin c solubilized in chamomile oil nanoemulsion. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2019;19:1232-1242. DOI: 10.2174/187152 0619666190408114732
  105. 105. Ortiz C, Morales L, Sastre M, Haskins WE, Matta J. Cytotoxicity and genotoxicity assessment of sandalwood essential oil in human breast cell lines MCF-7 and MCF-10A. Evidence-based Complementary and Alternative Medicine. 2016;2016:3696232. DOI: 10.1155/2016/3696232
  106. 106. Raghavendra RM, Nagarathna R, NagendrA HR, Gopinath KS, Srinath BS, Ravi BD, et al. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. European Journal of Cancer Care. 2007;16:462-474. DOI: 10.1111/j.136 5-2354.2006.00739.x
  107. 107. Lua PL, Salihah N, Mazlan N. Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer. Complementary Therapies in Medicine. 2015;23:396-404. DOI: 10.1016/j.ctim.2015.03.009
  108. 108. Pruthi S, Simon JA, Early AP. Current overview of the management of urogenital atrophy in women with breast cancer. The Breast Journal. 2011;17:403-408. DOI: 10.1111/j.1524-4741.2011.01089.x
  109. 109. Simões BM, Kohler B, Clarke RB, Stringer J, Novak-Frazer L, Young K, et al. Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors. Therapeutic Advances in Medical Oncology. 2018;10:1-11. DOI: 10.1177/1758835918766189
  110. 110. Halm MA, Baker C, Harshe V. Effect of an essential oil mixture on skin reactions in women undergoing radiotherapy for breast cancer: A pilot study. Journal of Holistic Nursing. 2014;32:290-303. DOI: 10.1177/0 898010114527184
  111. 111. Loizzo MR, Tundis R, Menichini F, Saab AM, Statti GA, Menichini F. Cytotoxic activity of essential oils from Labiatae and Lauraceae families against in vitro human tumor models. Anticancer Research. 2007;27:3293-3300
  112. 112. Emami SA, Asili J, Hossein Nia S, Yazdian-Robati R, Sahranavard M, Tayarani-Najaran Z. Growth inhibition and apoptosis induction of essential oils and extracts of Nepeta cataria L. on human prostatic and breast cancer cell lines. Asian Pacific Journal of Cancer Prevention. 2016;17:125-130. DOI: 10.7314/APJCP.2016.17.S3.125
  113. 113. Grecco SD, Martins EG, Girola N, de Figueiredo CR, Matsuo AL, Soares MG, et al. Chemical composition and in vitro cytotoxic effects of the essential oil from Nectandra leucantha leaves. Pharmaceutical Biology. 2015;53:133-137. DOI: 10.3109/13880209.2014.912238
  114. 114. El Hadri A, del Rio MG, Sanz J, Coloma AG, Idaomar M, Ozonas BR, et al. Cytotoxic activity of α-humulene and transcaryophyllene from Salvia officinalis in animal and human tumor cells. Anales de la Real Academia Nacional de Farmacia. 2010;76:343-356
  115. 115. Medina-Holguín AL, Holguín FO, Micheletto S, Goehle S, Simon JA, O’Connell MA. Chemotypic variation of essential oils in the medicinal plant, Anemopsis californica. Phytochemistry. 2008;69:919-927. DOI: 10.1016/j.phytoch em.2007.11.006
  116. 116. Begnini KR, Nedel F, Lund RG, Carvalho PH, Rodrigues MR, Beira FT, et al. Composition and antiproliferative effect of essential oil of Origanum vulgare against tumor cell lines. Journal of Medicinal Food. 2014;17(11):29-33. DOI: 10.1089/jmf.2013.0063
  117. 117. Soltanian S, Mohamadi N, Rajaei P, Khodami M, Mohammadi M. Phytochemical composition, and cytotoxic, antioxidant, and antibacterial activity of the essential oil and methanol extract of Semenovia suffruticosa. Avicenna Journal of Phytomedicine. 2019;9:143-152

Written By

Isadora de Fátima Braga Magalhães, Carla Junqueira Moraga Tellis, Kátia da Silva Calabrese, Ana Lucia Abreu-Silva and Fernando Almeida-Souza

Submitted: November 12th, 2019 Reviewed: February 17th, 2020 Published: May 16th, 2020